This upcoming webinar is a SOT Computational Toxicology and Drug Discovery Toxicology Specialty Section (DDTSS) co-sponsored event.
Artificial Intelligence in the Design of Safer Medicines – Science or Science Fiction?
June 25, 2020
Time: 11 am EDT (1 hour)
Nigel Greene, PhD, Director, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, AstraZeneca
There are strong economic drivers to reduce the costs associated with the discovery of new medicines. However, drug discovery and development are multiparameter optimization problems that require a novel medicine to have a fine balance between its efficacy, ADME properties and safety. Although the number of clinical failures from safety has been reduced in recent years, there are still improvements that could be made. Data science and artificial intelligence is a potential method to both improve the safety profile of new drugs as well as reduce the costs and time to bring these to the clinic. This talk will highlight some of the current investments in computational methods and highlight some of the key gaps in realizing these benefits.
Registration is required. Register here